DAWSON GEOPHYSICAL CO (DWSN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 80M 160M 240M FY09: 90.4M FY10: 108.3M FY11: 151M FY12: 196.3M FY13: 134.5M FY14: 118.8M FY15: 234.7M FY16: 137.6M FY17: 156.5M FY18: 154.2M FY19: 145.8M FY20: 86.1M FY21: 24.7M FY22: 51.6M FY23: 96.8M FY24: 74.2M FY25: 75.6M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Gross Profit Annual

-45M -30M -15M 0 15M 30M 45M FY09: 4.9M FY10: 147.6K FY11: 18.2M FY12: 26.8M FY13: -7.4M FY14: -13.5M FY17: -38M FY18: -25M FY19: -16.2M FY20: -14M FY21: -29.2M FY22: -22.2M FY23: -13.1M FY24: -4.5M FY25: -1.7M FY09 FY11 FY13 FY17 FY19 FY21 FY23 FY25

Revenue minus cost of sales. This filer tags no gross profit of its own..

Operating Income Annual

-60M -40M -20M 0 20M 40M 60M FY09: 4.9M FY10: 147.6K FY11: 18.2M FY12: 26.8M FY13: -7.4M FY14: -13.5M FY15: -40.7M FY16: -47.5M FY17: -38M FY18: -25M FY19: -16.2M FY20: -14M FY21: -29.2M FY22: -22.2M FY23: -13.1M FY24: -4.5M FY25: -1.7M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-45M -30M -15M 0 15M 30M 45M FY09: 1.9M FY10: -1.2M FY11: 10.8M FY12: 15.7M FY13: -6.3M FY14: -9.5M FY15: -26.3M FY16: -38.3M FY17: -31.8M FY18: -24.4M FY19: -15.2M FY20: -13.2M FY21: -29.1M FY22: -18.6M FY23: -12.1M FY24: -4.1M FY25: -1.9M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

0 70M 140M 210M FY09: 85.5M FY10: 108.2M FY11: 132.9M FY12: 169.5M FY13: 141.9M FY14: 132.4M FY17: 194.5M FY18: 179.2M FY19: 162M FY20: 100.1M FY21: 53.9M FY22: 73.8M FY23: 109.9M FY24: 78.7M FY25: 77.3M FY09 FY11 FY13 FY17 FY19 FY21 FY23 FY25

Operating Cash Flow Annual

-30M -15M 0 15M 30M 45M FY09: 20.7M FY10: 5.2M FY11: 34.2M FY12: 39.3M FY13: 23M FY14: 9.3M FY15: 20.6M FY16: 8.7M FY17: -6.7M FY18: 12.9M FY19: 9.5M FY20: 19.6M FY21: -16.1M FY22: -3.3M FY23: 814K FY24: -1.9M FY25: 14M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-24M -16M -8M 0 8M 16M 24M FY09: 19.3M FY10: -3.1M FY11: 12.2M FY12: 7.3M FY13: 21.1M FY14: 7.9M FY15: 13.8M FY16: 491K FY17: -15.4M FY18: -2.9M FY19: 5.1M FY20: 16.8M FY21: -16.6M FY22: -4.7M FY23: -2.9M FY24: -3.7M FY25: 7.1M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 15M 30M 45M FY09: 19.3M FY10: 19.2M FY11: 21.5M FY12: 7.3M FY13: 7.3M FY14: 7.3M FY15: 20.7M FY16: 22.7M FY17: 22.8M FY18: 22.9M FY19: 23.2M FY20: 23.4M FY21: 23.6M FY22: 25M FY23: 26.8M FY24: 30.9M FY25: 31M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-2.10 -1.40 -0.70 0.00 0.70 1.40 2.10 Q4 '11: 0.53 Q1 '12: 0.82 Q2 '12: 0.70 Q3 '12: 0.70 Q4 '12: -0.11 Q1 '13: -0.39 Q2 '13: -0.48 Q3 '13: -0.71 Q4 '13: -0.43 Q1 '14: -0.60 Q2 '14: -0.96 Q3 '14: -1.06 Q4 '14: -1.33 Q1 '15: -1.82 Q2 '15: -1.83 Q3 '15: -1.68 Q4 '15: -1.28 Q1 '16: -1.31 Q2 '16: -1.30 Q3 '16: -1.74 Q4 '16: -1.84 Q1 '17: -1.84 Q2 '17: -1.96 Q3 '17: -1.52 Q4 '17: -1.40 Q1 '18: -1.07 Q2 '18: -0.66 Q3 '18: -0.76 Q4 '18: -1.06 Q1 '19: -1.00 Q2 '19: -1.24 Q3 '19: -0.92 Q4 '19: -0.66 Q1 '20: -0.61 Q2 '20: -0.06 Q3 '20: -0.48 Q4 '20: -0.56 Q1 '21: -0.82 Q2 '21: -1.26 Q3 '21: -1.26 Q4 '21: -1.22 Q1 '22: -1.06 Q2 '22: -0.98 Q3 '22: -0.93 Q4 '22: -0.75 Q1 '23: -0.71 Q2 '23: -0.59 Q3 '23: -0.51 Q4 '23: -0.45 Q1 '24: -0.24 Q2 '24: -0.18 Q3 '24: -0.16 Q4 '24: -0.13 Q1 '25: -0.29 Q2 '25: -0.25 Q3 '25: -0.11 Q4 '25: -0.06 Q1 '26: 0.16 Q2 '26: 0.13 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.